WO2001039749A3 - Fast dissolving composition with prolonged sweet taste - Google Patents

Fast dissolving composition with prolonged sweet taste Download PDF

Info

Publication number
WO2001039749A3
WO2001039749A3 PCT/IN2000/000113 IN0000113W WO0139749A3 WO 2001039749 A3 WO2001039749 A3 WO 2001039749A3 IN 0000113 W IN0000113 W IN 0000113W WO 0139749 A3 WO0139749 A3 WO 0139749A3
Authority
WO
WIPO (PCT)
Prior art keywords
sweet taste
fast dissolving
dissolving composition
prolonged sweet
prolonged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2000/000113
Other languages
French (fr)
Other versions
WO2001039749A2 (en
Inventor
Amarjit Singh
Rajesh Jain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to BR0015994-8A priority Critical patent/BR0015994A/en
Priority to US10/148,651 priority patent/US7122198B1/en
Priority to AU32214/01A priority patent/AU3221401A/en
Priority to EP00993237A priority patent/EP1235561A2/en
Priority to UA2002054388A priority patent/UA78485C2/en
Publication of WO2001039749A2 publication Critical patent/WO2001039749A2/en
Publication of WO2001039749A3 publication Critical patent/WO2001039749A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A novel fast dissolving pharmaceutical composition in solid dosage form with prolonged sweet taste which comprises (a) at least one pharmaceutically active agent, (b) at least one water soluble sugar, (c) at least one non-sugar sweetener in normal fast release form and (d) at least one non-sugar sweetener in a mucoadhesive slow release form.
PCT/IN2000/000113 1999-11-30 2000-11-24 Fast dissolving composition with prolonged sweet taste Ceased WO2001039749A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BR0015994-8A BR0015994A (en) 1999-11-30 2000-11-24 Fast dissolving composition with prolonged sweet taste
US10/148,651 US7122198B1 (en) 1999-11-30 2000-11-24 Fast dissolving composition with prolonged sweet taste
AU32214/01A AU3221401A (en) 1999-11-30 2000-11-24 Fast dissolving composition with prolonged sweet taste
EP00993237A EP1235561A2 (en) 1999-11-30 2000-11-24 Fast dissolving composition with prolonged sweet taste
UA2002054388A UA78485C2 (en) 1999-11-30 2000-11-24 Fast dissolving pharmaceutical composition with prolonged sweet taste and method for manufacture thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1514DE1999 1999-11-30
IN1514/DEL/99 1999-11-30

Publications (2)

Publication Number Publication Date
WO2001039749A2 WO2001039749A2 (en) 2001-06-07
WO2001039749A3 true WO2001039749A3 (en) 2002-02-14

Family

ID=11092722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2000/000113 Ceased WO2001039749A2 (en) 1999-11-30 2000-11-24 Fast dissolving composition with prolonged sweet taste

Country Status (9)

Country Link
US (1) US7122198B1 (en)
EP (1) EP1235561A2 (en)
AU (1) AU3221401A (en)
BR (1) BR0015994A (en)
CZ (1) CZ300615B6 (en)
RU (1) RU2216319C1 (en)
UA (1) UA78485C2 (en)
WO (1) WO2001039749A2 (en)
ZA (1) ZA200204193B (en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1309315B1 (en) * 2000-08-18 2006-06-14 Pharmacia Corporation Rapidly disintegrating oral formulation of valdecoxib
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
WO2004082664A1 (en) * 2003-03-21 2004-09-30 Ranbaxy Laboratories Limited Water-soluble tablets of metformin
TW200637564A (en) * 2004-12-27 2006-11-01 Kowa Co Orally disintegrable solid preparation comprising povidone-iodine
TWI383809B (en) * 2005-06-29 2013-02-01 Otsuka Pharma Co Ltd Orally disintegrating powder comprising cilostazol
US7776831B2 (en) 2006-02-01 2010-08-17 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
CA2687118A1 (en) 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007136845A2 (en) 2006-05-19 2007-11-29 Somaxon Pharmaceuticals, Inc. Low-dose doxepin for treatment of sleep disorders in elderly patients
JP2009537554A (en) * 2006-05-19 2009-10-29 ソマクソン ファーマシューティカルズ インコーポレイテッド Low-dose doxepin formulations, including oral, sublingual and rapid-melt formulations, and uses thereof for treating insomnia
DE102007034102A1 (en) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abrasion-resistant and free-flowing glycocyamine-containing moldings and process for their preparation
WO2009084017A2 (en) * 2007-10-10 2009-07-09 Rubicon Research Private Limited Taste-masked orally disintegrating tablets of memantine hydrochloride
NZ585219A (en) * 2007-11-09 2012-11-30 Intervet Int Bv Fast release solid formulation, preparation and use thereof
WO2009092002A1 (en) * 2008-01-17 2009-07-23 Duquesne University Of The Holy Spirit Antiretroviral drug formulations for treatment of children exposed to hiv/aids
WO2009118589A2 (en) 2008-03-24 2009-10-01 Wockhardt Research Centre Orally disintegrating compositions of rhein or diacerein
WO2009124357A1 (en) * 2008-04-10 2009-10-15 Malvin Leonard Eutick Fast dissolving oral formulations for critical drugs
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
WO2010143207A1 (en) * 2009-06-11 2010-12-16 Rubicon Research Private Limited Taste-masked oral formulations of influenza antivirals
PT2442821T (en) 2009-06-18 2017-09-29 Allergan Inc Safe desmopressin administration
EP2482822B1 (en) 2009-10-01 2018-08-01 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
BRPI1002023A2 (en) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A fast dissolving solid dosage form for treating bacterial infections
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US20170100328A1 (en) * 2011-02-04 2017-04-13 Joseph E. Kovarik Bioadhesive Strip and Method of Using Same
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
KR101803693B1 (en) * 2011-03-18 2017-11-30 페브리스 바이오-텍 리미티드 Compositions and methods for treating multi-drug resistant malaria
CN103596551B (en) * 2011-06-08 2017-02-22 Lts勒曼治疗系统股份公司 Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
BR112014027352B1 (en) 2012-05-02 2022-10-25 New Market Pharmaceuticals PHARMACEUTICAL COMPOSITIONS FOR DIRECT SYSTEMIC INTRODUCTION
WO2013175511A1 (en) * 2012-05-24 2013-11-28 V.B. Medicare Pvt. Ltd. Taste masked pharmaceutical compositions
MX2015004940A (en) 2012-10-18 2015-12-09 Neuralight Hd Llc Treatment of depression and ptsd.
CN104884064A (en) 2012-12-24 2015-09-02 纽洛佳斯特拉斯公司 Methods for treating gi tract disorders
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
CN105078914B (en) * 2015-07-17 2018-09-18 贵州大学 Levodropropizine includes composition dispersible tablets and preparation method thereof
CN106822007B (en) 2015-09-11 2021-12-31 西姆莱斯股份公司 Oral preparation
RU2611411C1 (en) * 2016-01-11 2017-02-21 Общество с ограниченной ответственностью "Трейдсервис" Dispersible in water acetylcysteine tablet and method of manufacturing thereof
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US11517545B2 (en) 2016-12-15 2022-12-06 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
GR1009573B (en) * 2018-03-28 2019-08-12 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Effervescent pharmaceutical tablets comprising hydrocorrtisone sodium phosphate
FI3787596T3 (en) * 2018-05-02 2025-09-29 Ferring Bv Improved pharmaceutical formulations
WO2019246074A1 (en) * 2018-06-18 2019-12-26 Synergistic Therapeutics, Llc Sublingual antidepressant and antianxiety tablet
AU2021244054A1 (en) * 2020-03-23 2022-10-13 Aavishkar Oral Strips Private Limited Taste masked and rapidly disintegrating ultra thin iron orodispersible film and a process thereof
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229000A2 (en) * 1986-01-07 1987-07-15 Warner-Lambert Company Encapsulation composition for use with chewing gum and edible products
EP0452268A2 (en) * 1990-04-10 1991-10-16 Warner-Lambert Company Substained release of active agents from bioadhesive microcapsules
FR2766089A1 (en) * 1997-07-21 1999-01-22 Prographarm Lab IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561C2 (en) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Process for the production of porous tablets
ATE172637T1 (en) * 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd INTRABUCCAL DISINTEGRATION PREPARATION AND PRODUCTION THEREOF
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229000A2 (en) * 1986-01-07 1987-07-15 Warner-Lambert Company Encapsulation composition for use with chewing gum and edible products
EP0452268A2 (en) * 1990-04-10 1991-10-16 Warner-Lambert Company Substained release of active agents from bioadhesive microcapsules
FR2766089A1 (en) * 1997-07-21 1999-01-22 Prographarm Lab IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY

Also Published As

Publication number Publication date
UA78485C2 (en) 2007-04-10
RU2002117306A (en) 2004-01-20
CZ300615B6 (en) 2009-07-01
WO2001039749A2 (en) 2001-06-07
ZA200204193B (en) 2003-05-27
BR0015994A (en) 2002-08-06
AU3221401A (en) 2001-06-12
RU2216319C1 (en) 2003-11-20
CZ20021855A3 (en) 2002-11-13
EP1235561A2 (en) 2002-09-04
US7122198B1 (en) 2006-10-17

Similar Documents

Publication Publication Date Title
BR0015994A (en) Fast dissolving composition with prolonged sweet taste
WO2004069198A3 (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
EP0839526A3 (en) Solid pharmaceutical preparation with fast buccal disintegration or dissolution
CA2286753A1 (en) Solid pharmaceutical preparation
DK1796484T3 (en) confectionery product
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
WO2002053100A3 (en) Pharmaceutical dosage form for oral administration of low molecular weight heparin
CA2232450A1 (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
BR9912979B1 (en) orally administrable pharmaceutical composition, chewing tablet, capsule and use of chitosan.
CA2370556A1 (en) Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
WO2005025499A3 (en) Hydrophobic drug compositions containing reconstitution enhancer
WO2000051593A3 (en) Oral drug delivery system
DK1183014T3 (en) Flavored controlled release oral pharmaceutical compositions
WO2004013153A3 (en) Macrolide compounds endowed with antiinflammatory activity
EP2008650A3 (en) Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol
WO1998000114A3 (en) Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
WO2004075875A8 (en) Dosage form having a saccharide matrix
AU2001262011A1 (en) A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
HK1045113A1 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
WO2002024203A3 (en) Controlled release formulations for oral administration
WO1998038983A3 (en) Swallow tablet comprising paracetamol
WO2005007137A3 (en) Tablets containing ambroxol
WO2000010526A3 (en) New oral formulation for 5-ht4 agonists or antagonists
AU2003238644A1 (en) Stable compositions of water sensitive ingredients
NO20015480L (en) Microgranules that are not soluble in gastric juice, methods for achieving the same and pharmaceutical preparations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2002/04193

Country of ref document: ZA

Ref document number: 200204193

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: PV2002-1855

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 2000993237

Country of ref document: EP

ENP Entry into the national phase

Ref country code: RU

Ref document number: 2002 2002117306

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 10148651

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000993237

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV2002-1855

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 2000993237

Country of ref document: EP